Kang Ze Pharmaceutical (83 1397) recently released its 20021annual report. During the reporting period, the company achieved operating income of 2,356,265,512.01yuan, a year-on-year decrease of 1 1.83%. The net profit attributable to shareholders of listed companies was 97,647, 1 19.4 1 yuan, up 73.2 1% year-on-year.
During the reporting period, the net cash flow from operating activities was14,861640.5438+0 yuan, and the net assets attributable to shareholders of listed companies at the end of 202/kloc-0 were 795,322, 1 16.72 yuan.
During the reporting period, the company's revenue scale decreased slightly year-on-year, mainly due to the continuous deepening of the national medical system reform and the continuous expansion and expansion of quantity procurement. The prices of most original research and generic drugs that passed the consistency evaluation continued to decline, and the steady growth of demand could not completely offset the income reduction caused by the rapid price decline. The development of some businesses has been affected by the COVID-19 epidemic, and the business in a certain area has been affected in the aspects of store passenger flow, logistics efficiency and business negotiation.
During the reporting period, the comprehensive gross profit margin of the company's main business was 9.48%, an increase of 3. 1 1% over the same period of last year. The main reasons for the increase in comprehensive gross profit margin are as follows: during the reporting period, the company actively explored key product categories with market advantages, focused on developing key categories, and improved the overall gross profit margin of products by optimizing product structure; The company has continuously strengthened cooperation among manufacturers, made full use of its own business scale advantages and bargaining power, and comprehensively reduced the procurement cost and circulation cost of goods by purchasing directly from manufacturers, using mature and perfect warehousing and maintenance management systems and modern logistics parks. The comprehensive gross profit margin of its main business has gradually increased to 20 19. The company strictly controls various expenses, strengthens benefit management, and increases the collection of various funds to further reduce the company's operating costs and improve operating profits.